Australian laws and regulations limit the amount of information we can provide to the general public via our website. Our Consumer Medicine Information (CMI) leaflets are intended for patients who have been prescribed our products. They provide information on the safe and effective use of the prescription medicine. Our Product Information (PI) sheets are intended for healthcare professionals. They provide a summary of the essential scientific information for the safe and effective use of a prescription medicine.
DILAUDID® tablets and liquid
DILAUDID® & DILAUDID®HP INJECTIONS
MS CONTIN® tablets
MS MONO® capsules
ORDINE® oral solution
OxyNorm® capsules and liquid
® DILAUDID, MS CONTIN, MS MONO, NORSPAN, OXYCONTIN, OXYNORM, SEVREDOL and TARGIN are registered trade marks.
® ORDINE is a registered trade mark of Pfizer (Perth) Pty Ltd and is used under licence.
*Due to unforeseen manufacturing issues, DILAUDID® oral liquid (hydromorphone 1mg/mL) is unavailable. It is anticipated that supply will recommence in October 2017. If you are a patient, please speak with your doctor. Please call Mundipharma Medical Information (1800-188-009) for information on Mundipharma products.